Literature DB >> 8764049

cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo.

K Soares1, D Y Hwang, R Ramakrishnan, M C Schmidt, D J Fink, J C Glorioso.   

Abstract

Latency-associated promoter 1 (LAP1) of herpes simplex virus type 1 is required to generate a series of latency-associated transcripts (LATs) in sensory neurons of latently infected animals. Sequence analysis and DNA binding studies have suggested the existence of several cis-acting elements within LAP1 that are potentially important for promoter function, although their role in LAT gene expression during latency is largely unexplored. In this report, we present evidence that the LAP1 TATA box is essential for transcription initiation in vitro. A reduction in LAT synthesis measured by in situ hybridization and reverse transcription-PCR (RT-PCR) of rat brain tissue latently infected with a LAP1 TATA substitution virus demonstrated that this sequence was required for full LAP1 activity in vivo. Analysis of additional site-directed and 5'-deletion mutants of LAP1 by in vitro transcription-primer extension assays showed that upstream elements including the USF and cyclic AMP response element (CRE) site specifically contributed to LAP1 function and that sequences beginning at position -620 relative to the transcription start site were essential for full promoter activity. The combination of deleting USF, CRE, and TATA completely abolished LAT expression in the brain, identifying these as essential elements for the neuron-specific functioning of LAP1 during latency. Mutation of the transcription start site did not abolish transcription, suggesting the absence of an initiator element. However, one of the most exciting findings from this study is that the region downstream of the TATA box appears to contain a true enhancer that is not only essential for transcription, but also functional when positioned 1.6 kb downstream of the start site of transcription. It was concluded that (i) the TATA box was essential for full transcriptional activity from LAP1 both in vitro and in vivo, (ii) the USF element and CRE contribute to LAP1 function during latency in combination with the TATA element, (iii) multiple trans-acting factors besides the USF- and CRE-binding proteins were required for full promoter activity in vitro, and (iv) sequences downstream of the TATA box enhanced promoter activity in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764049      PMCID: PMC190496     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  DNA sequence requirements for transcriptional initiator activity in mammalian cells.

Authors:  R Javahery; A Khachi; K Lo; B Zenzie-Gregory; S T Smale
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

2.  An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation.

Authors:  S L Deshmane; M Nicosia; T Valyi-Nagy; L T Feldman; A Dillner; N W Fraser
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

3.  In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts.

Authors:  K A Rader; C E Ackland-Berglund; J K Miller; J S Pepose; D A Leib
Journal:  J Gen Virol       Date:  1993-09       Impact factor: 3.891

4.  Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.

Authors:  R Ramakrishnan; D J Fink; G Jiang; P Desai; J C Glorioso; M Levine
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 5.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region.

Authors:  M Nicosia; S L Deshmane; J M Zabolotny; T Valyi-Nagy; N W Fraser
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter.

Authors:  C J Huang; S A Goodart; M K Rice; J F Guzowski; E K Wagner
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.

Authors:  J J Kenny; F C Krebs; H T Hartle; A E Gartner; B Chatton; J M Leiden; J P Hoeffler; P C Weber; B Wigdahl
Journal:  Virology       Date:  1994-04       Impact factor: 3.616

9.  cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif.

Authors:  E Schreiber; A Tobler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

10.  Decreased reporter gene expression during latent infection with HSV LAT promoter constructs.

Authors:  T P Margolis; D C Bloom; A T Dobson; L T Feldman; J G Stevens
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

View more
  8 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression.

Authors:  M D Galibert; S Carreira; C R Goding
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 3.  Herpes simplex virus evolved to use the human defense mechanisms to establish a lifelong infection in neurons--a review and hypothesis.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

Review 4.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 5.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

6.  Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

Authors:  R H Lachmann; S Efstathiou
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 7.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

8.  Influence of herpes simplex virus 1 latency-associated transcripts on the establishment and maintenance of latency in the ROSA26R reporter mouse model.

Authors:  M P Nicoll; J T Proença; V Connor; S Efstathiou
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.